What Is the Difference Between MDEL and MDL? A Complete Guide to Canadian Registration Requirements
Views:18
Time:2026-07-30 11:45:52

Many enterprises get confused about the two licensing systems, MDEL and MDL, under the supervision of Health Canada. This article fully breaks down the Canadian medical device registration pathways to help enterprises smoothly gain market access.

一、Risk Classification of Medical Devices in Canada



Canada categorizes medical devices into four classes: Class I, II, III and IV, ranked from lowest to highest risk. Higher risk levels bring stricter registration and regulatory requirements. Licensing rules vary greatly for different market participants, which can be summarized as follows:

Class I devices:Manufacturers must hold an MDEL; all importers and distributors also need an MDEL.
Class II / III / IV devices:Manufacturers shall apply for an MDL for their products; corresponding importers and distributors are still required to hold an MDEL.

In short: MDEL is an establishment access license, while MDL is a product marketing license. All importers and distributors of every device class must hold an MDEL. In addition, manufacturers of high-risk Class II and above devices need to obtain a separate MDL for their products.


二、MDEL



MDEL stands for Medical Device Establishment Licence. It is an establishment qualification issued by Health Canada to manufacturers of Class I medical devices, as well as importers and distributors of all device classes. Only licensed companies are permitted to import or distribute medical devices within Canada.

(一)Core Documents for MDEL Application
Applicants need to submit the official FRM-0292 application form, which covers key information including application type, corporate name and address, authorized representative information, statements for sales/import of medical devices, manufacturer identity statement for Class I device producers, manufacturer and classification information of intended imported/distributed products, physical storage address of documentation procedures, and compliance declarations signed by senior corporate management.

Different entities shall prepare corresponding quality management procedures:
Importers & Distributors:Procedures for complaint handling, product recall and distribution record-keeping. Importers must additionally establish mandatory adverse event reporting (vigilance system). Importers handling Class II–IV devices shall add procedures covering product storage, delivery, installation, corrective actions and after-sales service.
Class I Device Manufacturers::Procedures for complaint handling, recall management, distribution records and mandatory adverse event reporting.

(二)MDEL Fee Rules

MDEL adopts a fixed annual fee standard. The Canadian government fiscal year runs from April 1 to March 31 of the following year. New applications, reinstatement of suspended licences and Annual Review Licence (ARL) renewal all apply the same fixed charge; no fees are charged for MDEL information amendments.


三、MDL



MDL refers to Medical Device Licence, a mandatory marketing certification for high-risk Class II, III and IV medical devices in Canada, which shall be applied for by product manufacturers.


(一)Latest Official Application Fees (Effective April 1, 2026)

New registration of Class II medical devices: CAD 643
Licence amendment for Class II medical devices: CAD 331
New registration of Class III medical devices: CAD 13,926


(二)Core Framework of MDL Technical Documentation
  • Administrative documents: Cover letter, application form, glossary, quality management system certification, historical regulatory communication records, master file authorization letter, etc.
  • Product background: Product overview, intended use and contraindications, global marketing history, supplementary background materials.
  • Non-clinical research: Applicable standards, verification test data, shelf-life and packaging validation, non-clinical references and other supporting non-clinical evidence.
  • Clinical evidence: Summary of overall clinical data, clinical trial results and supplementary clinical materials.
  • Labelling & promotional materials: Outer packaging labels, instructions for use, electronic labelling, physician/patient-specific labelling, operation manuals and product brochures.


四、Conclusion



Canadian medical device registration involves regulatory interpretation, dossier preparation, process follow-up and official communication, with intricate details. Any omission may extend registration cycles and raise compliance costs. Feel free to consult Wiselink Regulatory Consulting for further inquiries.


Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.